Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000002446
JPRN-UMIN000002446
Completed
Phase 1

Radiation dosimetry, safety and pharmacokinetics of [11C]telmisartan as well as optimization of PET imaging in healthy volunteers - Pharmacokinetics of [11C]telmisartan in healthy volunteers (TEL-0)

Foundation for Biomedical Research and Innovation0 sites9 target enrollmentSeptember 7, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHypertension

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hypertension
Sponsor
Foundation for Biomedical Research and Innovation
Enrollment
9
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 7, 2009
End Date
March 1, 2010
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\. Renal artery stenosis, bilaterally or unilaterally after nephrectomy 2\. Hyperkalemia 3\. Liver or renal dysfunction 4\. Cerebrovascular disorders 5\. Hypotension 6\. Severe bradycardia, or WPW or LGL syndrome by ECG 7\. Medication or dietary supplement including St. John's wort within 7 days prior to PET study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Radiation therapy in locally advanced rectal cancerHealth Condition 1: C20- Malignant neoplasm of rectum
CTRI/2023/10/059109Dr Raju Das
Not yet recruiting
Phase 1
A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid TumorsSolid Tumors
NCT06553846Fudan University50
Active, not recruiting
Not Applicable
A dose ranging, safety and pharmacokinetics study of Candesartan Cilexetil in hypertensive pediatric subjects 1 to less than 6 years of age a 4-week, multicenter, randomised, double blind study with a 1 year open-label, follow-up period - NDHypertension in pediatric subjects 10020772MedDRA version: 8.1Level: PTClassification code 10020772Term: Hypertension
EUCTR2004-004264-75-ITASTRAZENECA125
Completed
Phase 1
PK in Pts With HRPC & Skeletal MetastesProstatic Neoplasms
NCT00667537Bayer6
Recruiting
Not Applicable
Measurement of radiation dose of the patient in neuro angiographycerebral aneurysm, cerebral arteriovenous malformation, dural cerebral arteriovenous fistula etc.
JPRN-UMIN000038076Toranomon Hospital300